DY002: Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract Surgery

Clinical trial NCT00596492 · TERMINATED

Trial details

NCT number: NCT00596492
Sponsor: Aqumen Biopharmaceuticals, N.A.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Mature Cataracts

Start date: 2008-05-01
Primary completion: 2008-09-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.